Silk Road Medical Inc (NAS:SILK)
$ 22.04 -0.7 (-3.08%) Market Cap: 869.34 Mil Enterprise Value: 800.08 Mil PE Ratio: 0 PB Ratio: 6.09 GF Score: 78/100

Silk Road Medical Inc at JPMorgan Healthcare Conference Transcript

Jan 15, 2020 / 12:00AM GMT
Release Date Price: $41.73 (+2.28%)
Robert Justin Marcus
JP Morgan Chase & Co, Research Division - Analyst

Welcome, everyone. I'm Robbie Marcus, the med tech analyst at JPMorgan. I'm very happy to host for the first time at the conference Silk Road as a public company, and my pleasure to introduce Erica Rogers, the CEO.

Erica J. Rogers
Silk Road Medical, Inc - President, CEO & Director

Thank you, Robbie, and let me start by saying thank you for attending here late in the day, and it is my honor and privilege to be in front of all of you and certainly my honor to talk about Silk Road Medical. So let's get right into it.

Silk Road Medical is establishing an entirely new, minimally invasive procedural category. And we believe that this category, this new procedure has the possibility to become the standard of care. And that procedure is known as TCAR, TransCarotid Artery Revascularization, for the prevention of stroke. And because we believe that this procedure has the possibility to become the standard of care in the treatment of carotid artery disease, we take outcomes very

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot